These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19672572)

  • 1. [Comorbidity of substance use disorders and attention-deficit hyperactivity disorders: pathogenesis and therapy].
    Fallgatter AJ; Jacob CP
    Nervenarzt; 2009 Sep; 80(9):1015-21. PubMed ID: 19672572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
    Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
    Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult ADHD and substance abuse: diagnostic and treatment issues.
    Kalbag AS; Levin FR
    Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].
    Kapitány-Fövény M; Barta C; Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Coetzee C; Luderer M; Schellekens A; Matthys F; Demetrovics Z;
    Psychiatr Hung; 2020; 35(4):435-447. PubMed ID: 33263293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.
    McGough JJ; Smalley SL; McCracken JT; Yang M; Del'Homme M; Lynn DE; Loo S
    Am J Psychiatry; 2005 Sep; 162(9):1621-7. PubMed ID: 16135620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.
    Bukstein OG
    Expert Rev Neurother; 2006 Apr; 6(4):541-9. PubMed ID: 16623653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder (ADHD) and substance use disorders.
    Wilson JJ; Levin FR
    Curr Psychiatry Rep; 2001 Dec; 3(6):497-506. PubMed ID: 11707164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attention deficit hyperactivity disorder and substance use in adulthood-Guideline-conform diagnostics and treatment].
    Kölle M; Philipsen A; Mackert S
    Nervenarzt; 2023 Jan; 94(1):47-57. PubMed ID: 36633607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
    Regan T; Tubman J
    Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
    [No Abstract]   [Full Text] [Related]  

  • 11. [International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD].
    Crunelle CL; van den Brink W; Schellekens A; van de Glind G; Icasa Consortium B; Matthys F
    Tijdschr Psychiatr; 2019; 61(7):477-487. PubMed ID: 31372969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations.
    Sullivan MA; Rudnik-Levin F
    Ann N Y Acad Sci; 2001 Jun; 931():251-70. PubMed ID: 11462745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attention deficit hyperactivity disorder (ADHD) and addiction].
    Hässler F; Reis O
    MMW Fortschr Med; 2010 May; 152(18):46-8. PubMed ID: 20514764
    [No Abstract]   [Full Text] [Related]  

  • 14. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
    Paslakis G; Schredl M; Alm B; Sobanski E
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy].
    Dirks H; Scherbaum N; Kis B; Mette C
    Fortschr Neurol Psychiatr; 2017 Jun; 85(6):336-344. PubMed ID: 28645126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
    Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
    Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
    Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
    Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
    Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.